WASHINGTON (AP) – U.S. health regulators have authorized a new antibody drug that targets the omicron variant. The announcement Friday is a key step in restocking the nation’s supply of drugs that are effective against the latest COVID-19 variant. Eli Lilly began working on the drug last year after its previous antibody therapy was shown…… MORE
